News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AV Therapeutics Announces Collaboration With DavosPharma to Manufacture Chemotherapeutic Drug Capridine



2/5/2014 9:41:31 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK, Feb. 5, 2014 (GLOBE NEWSWIRE) -- AV Therapeutics, Inc., ("AV Therapeutics" or "the Company") (OTCQB:AVTH), a developer of cancer therapeutics and vaccines, today announced that it has entered into an agreement with DavosPharma, a New Jersey-based company with 40 years of experience manufacturing drugs for the biotech industry, to assist in the Good Manufacturing Practices (GMP) synthesis of its lead drug candidate Capridine.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES